Ghost Tree Capital »

Janux Therapeutics shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.6M 190k 45.43
2024-06-30 $2.1M 50k 41.89

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics